Sunday, July 21, 2024 | Baltimore, MD

Sheppard Pratt plans to open center to research and treat people with psychedelic drug

June 2, 2022

Sheppard Pratt, the Towson-based behavioral health provider, said it is opening a new center to provide care for hard-to-treat illnesses that will include use of psilocybin, a psychedelic medication. Psilocybin will be used in research at a center within Sheppard Pratt’s new Institute for Advanced Diagnostics and Therapeutics, which will bring together a range of clinicians and treatments. Sometimes called magic mushrooms, psilocybin has shown to be effective in clinical trials for treatment-resistant depression and other mood disorders, though it remains illegal at the federal level, where it’s listed as a schedule 1 drug under the U.S. Controlled Substance Act.

Article Source: Baltimore Sun

The Morning Rundown

We’re staying up to the minute on the issues shaping the future. Join us on the newsletter of choice for Maryland politicos and business leaders. It’s always free to join and never a hassle to leave. See you on the inside.